REG - Tristel PLC - Director Appointment

TristelAnnouncement

24/12/2020 07:00

RNS Number : 7336J
  
Tristel PLC
  
24 December 2020
  
 

Tristel plc
("Tristel" or the "Company")
 
Director Appointment
 
Tristel plc (AIM: TSTL), leading manufacturer of infection prevention products, announces the appointment of Caroline Stephens to the Board as an Independent Non-Executive Director effective from 1 January 2021.
 
Caroline's executive career has been spent in global healthcare, marketing, and digital transformation, working for Johnson & Johnson for 26 years in multiple leadership roles.
 
Caroline holds a board advisory role with global digital transformation consultants CI&T.  
 
It is expected that Caroline will join Tristel's Audit, Remuneration and Nomination committees.
 
Commenting on the appointment, Paul Swinney, CEO of Tristel, said: "I am delighted to welcome Caroline to the Board at such an exciting time for our Company. Caroline has extensive international and sector experience and we very much look forward to working with her."
 
For further information please contact:        
 




Tristel plc


Tel: 01638 721 500




Paul Swinney, Chief Executive Officer


 




Liz Dixon, Finance Director


 




 


 




Walbrook PR Ltd


Tel: 020 7933 8780 or tristel@walbrookpr.com




Paul McManus


Mob: 07980 541 893




Lianne Cawthorne


Mob: 07584 391 303




 


 




finnCap


Tel: 020 7220 0500




Geoff Nash/ Giles Rolls (Corporate Finance)


 




Alice Lane (ECM)


 



 
 
 



 
 
Regulatory disclosure - The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies.
 
Caroline Jane Stephens, 53, holds no ordinary shares in the Company and no options. Caroline Stephen's current and previous directorships/partnerships are as follows:
 
Current Directorships/Partnerships:
Rex Bakery Ltd
Glendevon Trading Ltd
Verve Portfolio Ltd 
 
Former Directorships/Partnerships held in last 5 years: 
None
 
Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
BOAUOUVRROUUUAA